EUVIMEDEUVIMED entdecken
Crossref

Is interleukin‐27 a real candidate for immunotherapies of multiple sclerosis?

Yoh Matsumoto

Clinical and Experimental Neuroimmunology · 2013

DOI: 10.1111/cen3.12014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Neuroimmunology, 2013. Verfasst von Yoh Matsumoto. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As interleukin ( IL )‐27 has immunosuppressive effects and blocks T h17 differentiation, some researchers have investigated the possibility of the use of IL ‐27 for treatment of autoimmune diseases including multiple sclerosis. However, it has now been shown that the functions of IL ‐27 are more pleomorphic than expected. Therefore, more detailed analysis is necessary before entering this phase.

Zitieren

APA

Matsumoto, Y. (2013). Is interleukin‐27 a real candidate for immunotherapies of multiple sclerosis?. Clinical and Experimental Neuroimmunology. https://doi.org/10.1111/cen3.12014

Vancouver

Matsumoto Y. Is interleukin‐27 a real candidate for immunotherapies of multiple sclerosis?. Clinical and Experimental Neuroimmunology. 2013. doi:10.1111/cen3.12014

BibTeX
@article{Matsumoto2013,
  author = {Matsumoto, Yoh},
  title = {Is interleukin‐27 a real candidate for immunotherapies of multiple sclerosis?},
  journal = {Clinical and Experimental Neuroimmunology},
  year = {2013},
  doi = {10.1111/cen3.12014}
}
Kostenlos starten →